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Background and Objective: Radiation therapy (RT) is part of standard adjuvant treatment
for breast cancer. Earlier studies demonstrated increased cardiac morbidity and mortal-
ity from this. Coronary Calcium scanning utilizing Multidetector Computed Tomography
(MDCT) can detect early atherosclerosis in coronary arteries by identifying the amount of
calcifications. In our study we employed these tools to detect occult atherosclerosis at
least 5 years following breast RT.
Methods:We evaluated 20 asymptomatic patients, <60 years old, treated with RT at least
5 years prior to enrollment. Nine received RT to the left and 11 to the right chest wall. The
median interval between RT and calcium scan was 8 years. All patients were treated with
external beam RT using tangential technique. All patients underwent MDCT to compute
volumetric and Agatston calcium scores of the coronary arteries and the aorta.
Results: Eleven patients had RT to the right chest wall, and eight had a calcium score of 0,
while two had minimally elevated scores and one patient had a significantly elevated score.
Meanwhile nine patients had RT to the left chest wall, and seven had a calcium score of
0. None had significantly elevated scores. In the aorta, 11 of 20 patients had a score of 0,
while 8 of 20 had minimally elevated scores.
Conclusion: In contrast to studies demonstrating increased cardiovascular morbidity, our
pilot study did not detect significant occult atherosclerosis using MDCT of the coronaries
and aorta of patients assessed five or more years following radiation for treatment of breast
cancer.
Keywords: calcium scanning, breast cancer, adjuvant radiation, coronary disease, atherosclerosis, agatston, calcium
volume score, DCIS
INTRODUCTION
Radiation therapy (RT) is a crucial part of standard adjuvant ther-
apy for breast cancer. Following publication of the NSABP B06
study in 1985, which demonstrated equivalence of breast conser-
vation surgery plus radiotherapy to modified radical mastectomy,
many women with early stage breast cancer have opted for breast
conservation. There are more than 2.5 million women in the
United States with a history of radiation exposure and are at long
term risk for cardiovascular disease (1). Several studies have shown
that these patients have an increased risk of morbidity and mor-
tality from ischemic heart disease (2, 3). Most of these studies
were done on patients treated between 1960 and 1980. More mod-
ern radiation techniques such as tangential fields reduce the heart
and aorta’s exposure to ionizing radiation, and subsequent studies
suggest a reduction in the risk of cardiovascular disease, however
longer follow up is lacking (4, 5).
Aforementioned studies examined the late and irreversible
effects of radiation on the cardiovascular system. One major
mechanism of radiation induced cardiac damage is accelerated
atherosclerosis and there are several screening tests available to
detect early atherosclerosis. Electron Beam CT and now Multide-
tector CT provides a rapid, non-invasive method for identifying
coronary artery calcifications from early atherosclerosis (6–8). The
Agatston calcium score (AGS) and the Calcium Volume Score
(CVS) are two methods of calcium score standardization that
define levels of calcium burden. Both scoring systems are prognos-
tic of future coronary cardiac events, and allow for the detection
of asymptomatic patients at risk for coronary disease.
To our knowledge, coronary CT calcium scores have never been
used to estimate coronary disease in asymptomatic patients pre-
viously treated with RT for breast cancer. We designed a study to
evaluate the coronary calcium score in this population and cor-
relate these findings with the laterality of cancer and with the
patient’s family history and risk factors. Because atherosclerosis is
a late effect of radiation, all patients included in our study had a
history of radiation at least 5 years prior to CT assessment. Due to
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greater inclusion of the heart in the radiation portals of left-sided
breast cancers compared to the right, coronary CT presented a
unique opportunity to study differential atherosclerosis due to
laterality of breast cancer after RT.
MATERIALS AND METHODS
STUDY DESIGN
The study population comprised of 20 patients who were treated
with RT for breast cancer. In an effort to exclude the confounding
issue of increased atherosclerosis that occurs naturally with age, we
only included patients who were 60 years of age or younger at the
time of radiation. Only those patients who had radiation at least
5 years before enrollment were eligible. Patients were ineligible if
clinical symptoms of coronary artery disease were present on ini-
tial history. Upon enrollment, each patient had a complete clinical
history taken, a laboratory work-up including lipid panel, and a
CT of the heart to determine the calcium scores of the coronary
arteries and aorta by both AGS and CVS. The method of score
calculation has been previously reported in detail (9). A cardiol-
ogist with expertise in cardiac imaging, who was blinded to the
patient’s laterality of breast cancer, evaluated each CT. This study
was approved by the Institutional Review Board and informed
consent was obtained on every patient.
PATIENT CHARACTERISTICS
Twenty patients who were previously treated for breast cancer with
radiotherapy were included in the study (Table 1). Median age was
50 years at the time of enrollment (range 39–60). All patients were
treated with external beam radiation using tangential techniques.
Treatment dosing ranged 4500–5040 cGy using 6 MV photons. The
fraction size was 200 cGy/day in patients whose separation from
medial to lateral beam entry point was 24 cm or less, and was
180 cGy/day for separations >24 cm. An independent jaw tech-
nique was used to reduce divergence into the underlying lung and
heart. A separate heart block was used if needed at the inferior
tangential border of left-sided treatments to keep the amount of
left ventricle irradiation to <10% of the total planned dose. The
tumor bed was boosted to a total dose of 6000–6600 cGy depend-
ing on final margin status using 6–12 MeV electrons. Wedges were
used during treatment to keep the dose within 5% of the prescribed
dose. Patients had CT simulation for radiation planning. The heart
was contoured and constraints per RTOG protocol guidelines were
followed to limit cardiac dose. Dosimetrists were instructed to keep
≤5% of the heart to ≥20 Gy for left-sided tumors and 0% of the
heart should receive ≥20 Gy for right-sided tumors.
Nine patients (patients 1–9) were treated for left breast cancer
and received radiation to the left breast and chest wall. The remain-
ing 11 patients were treated for right breast cancer and received
radiation to the right breast and chest wall (patients 10–20). Seven
patients received radiation at an outside institution (1, 4, 6, 8,
16, 18, 20). Two patients received radiation to the internal mam-
mary nodes (IMN). The median interval between the radiation
and the cardiac CT screen was 8 years with a range of 5–14 years
(Table 1).
Table 1 | Patient characteristics.
Patient no. Age
(years)








Risk factors for coronary
artery disease
1 51 45 6 LEFT 4975 1000 Lipids
2 43 35 8 LEFT 4500 1600 Lipids, HTN, FHxb
3 54 48 6 LEFT 4600 1800 Lipids
4 52 47 5 LEFT 4680 1400 Lipids, tobacco
5 43 36 7 LEFT 4600 2000 Lipids, FHx
6 54 49 5 LEFT 5040 1000 Lipids, FHx
7 39 34 5 LEFT 5000 1600c Lipids, tobacco
8 56 50 6 LEFT 4600 1000 Lipids
9 51 43 8 LEFT 5000 0c None
10 60 52 8 RIGHT 4600 1400 Lipids, HTN, FHx
11 51 43 8 RIGHT 5000 0d Lipids
12 50 45 5 RIGHT 5040 0c None
13 54 48 6 RIGHT 4680 1400 None
14 53 43 10 RIGHT 4600 1400 Lipids, HTN
15 40 30 10 RIGHT 4600 1400 None
16 48 40 8 RIGHT 4500 1600 Lipids
17 47 35 12 RIGHT 4600 1000 Lipids
18 55 47 8 RIGHT 5040 0e Lipids
19 52 38 14 RIGHT 4600 0 Lipids
20 57 48 9 RIGHT 4600 0 None
aTime period between RT and coronary CT.
bFHx, family history of CAD.
c4600 cGy given to left supraclavicular and left posterior axilla.
d4600 cGy given to internal mammary nodes (IMN).
eRadiation given to IMN and right supraclavicular fossa.
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No patients had symptoms of cardiac ischemia. Three patients
had hypertension controlled with diet and medications. Fifteen
patients had a history of hypercholesterolemia, in most cases
treated with diet and exercise. Four patients had a strong fam-
ily history of coronary artery disease. None of the patients had
diabetes.
IMAGE ACQUISITION PARAMETERS
A coronary CT with calcium score was performed in all patients.
All studies were performed on a 64-multidetector computed
tomography (MDCT) scanner (GE Healthcare). An unenhanced
sequence was performed to assess the volumetric and Agatston
coronary calcium scores [SmartScore (GE Healthcare); 120 kV;
440–500 mA; rotation time, 0.35 s]. The CT scans were evaluated
by a cardiologist who was blinded to the patient’s breast cancer
and radiation history.
RESULTS
Of the nine patients who received radiation to the left breast and
chest wall, none had significantly elevated calcium scores. Two
patients were found with minimal calcium scores (Patients 1 and
7). Both had hyperlipidemia and one had a history of smoking.
The remaining seven patients had a calcium score of 0 (Table 2).
Of the 11 patients who had radiation to the right breast and
chest wall, 8 had coronary calcium scores of 0. Two patients
had minimal calcium scores (patients 10 and 18), both had
hyperlipidemia and one had hypertension and a strong family his-
tory of CAD. Only one patient had a significantly elevated calcium
score (patient 19) that was above the 90th percentile for her age
and sex for her AGS and CVS in the LAD and LCX. Surprisingly,
she had a right breast cancer and received adjuvant radiation to
the right breast and chest wall. She was only 55 years old and had
no history or smoking or diabetes. Her interval between radiation
and the screening CT was 14 years. She had hypercholesterolemia
with a cholesterol of 236 and LDL of 154 and a history of inflam-
matory bowel disease. She was subsequently referred to have a
cardiac work up.
Calcium scores in the descending and ascending aorta were also
evaluated. Of the 20, only 8 patients had an elevated calcium score,
but none were above 25.
DISCUSSION
SIGNIFICANT FINDINGS
The coronary calcium score is a screening tool intended to detect
asymptomatic coronary atherosclerosis, and its prognostic value
for future coronary events has been validated (10). Years of accu-
mulated data point to excessive cardiac mortality in women who
have received adjuvant radiation for breast cancer or ductal car-
cinoma in situ (DCIS), and it is likely that radiation induced
accelerated coronary artery and aortic atherosclerotic disease is
contributory to this. Indeed, the calcium score has been recently
shown by Rademaker et al. (11) to be a useful tool in the evaluation



















AGAa CVSb AGA CVS AGA CVS AGA CVS AGA CVS AGA CVS
1 51 0 0 3 6 0 0 0 0 0 0 3 9
2 43 0 0 0 0 0 0 0 0 0 0 0 0
3 54 0 0 0 0 0 0 0 0 0 0 0 0
4 52 0 0 0 0 0 0 0 0 0 0 0 0
5 43 0 0 0 0 0 0 0 0 0 0 0 0
6 54 0 0 0 0 0 0 0 0 2 7 0 0
7 39 0 0 0 0 1 4 0 0 3 10 0 0
8 56 0 0 0 0 0 0 0 0 6 19 0 0
9 51 0 0 0 0 0 0 0 0 0 0 0 0
10 60 0 0 0 0 7 11 0 0 4 11 0 0
11 51 0 0 0 0 0 0 0 0 0 0 0 0
12 50 0 0 0 0 0 0 0 0 0 0 0 0
13 54 0 0 0 0 0 0 0 0 4 13 0 0
14 53 0 0 0 0 0 0 0 0 0 0 0 0
15 40 0 0 0 0 0 0 0 0 0 0 0 0
16 48 0 0 0 0 0 0 0 0 0 0 0 0
17 47 0 0 0 0 0 0 0 0 0 0 8 23
18 55 0 0 1 4 0 0 0 0 0 0 0 0
19 52 0 0 176 225 31 30 127 101 0 0 18 18
20 52 0 0 0 0 0 0 0 0 0 0 0 0
aAGA, Agatston score.
bCVS, calcium volume score.
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of radiation-related CAD in asymptomatic patients treated with
mediastinal irradiation for Hodgkin’s Lymphoma. This study
showed eight of the nine patients to have coronary atherosclerosis
with high Agatston scores.
We therefore designed a pilot study to assess the delayed effects
of adjuvant radiation for breast cancer. To our knowledge, this
study is the first to report calcium scores to estimate coronary
and aortic disease in patients previously treated with RT for breast
cancer. Special attention was made to note the laterality of radia-
tion exposure, personal and family history of risk factors, and time
interval between radiation and calcium score screening.
The AGS and the CVS were both used for calcium scoring on
each patient. Current guidelines for interpretation of coronary
artery calcium scores (12) suggest categorizing risk groups by
scores from 0 (very low risk), 1–10 (low risk), 11–100 (moderate
risk), 101–400 (moderately high risk), to>400 (high risk). After a
median of 8 years post adjuvant RT for DCIS or early breast cancer,
only 1 among 20 women had a calcium score higher than 25 for
any vessel (CVS 225 to the LAD). She was 52 years old at the time
of study, and was 38 when she was diagnosed with right-sided early
breast cancer and had lumpectomy followed by 4600 cGy given to
the right chest wall with no boost to the tumor bed. Her medical
history was only pertinent for hyperlipidemia, and had no other
personal or family history of other risk factors.
This patient had the longest interval between radiation expo-
sure and time of coronary calcium scanning (14 years). This find-
ing may suggest that a longer minimum screening interval may
be necessary to detect radiation induced atherosclerotic disease.
However, the patient with the next longest interval was 12 years
(patient 17), and her case is remarkably similar in that she was
diagnosed at age 35, and had calcium screening at age 47. She also
had a right-sided breast tumor and was treated with 4600 cGy fol-
lowed by an additional 1000 cGy boost to the tumor bed. She too
had only a history of hyperlipidemia, without personal or family
history of other risk factors. Despite similar age at presentation,
similar interval of radiation to screening time, and having had
1000 cGy more radiation, her highest calcium score was 25 (CVS)
to the descending aorta.
Meanwhile, 11 of the 20 patients had a calcium score of 0 for all
vessels. These included five patients with up to 5000 cGy to the left
side, and up to 2000 cGy additional boost to the left-sided tumor
bed. Additionally, one of these 11 patients had a smoking history
and two others had a significant family history of cardiac disease.
Most of the remaining patients had no calcium scores more than
10, reflecting minimal calcium burden and risk.
Given the proximity of the heart and great vessels to the left-
sided radiation portals – even accounting for tangential field
techniques – it is still notable that none of the patients with left-
sided breast cancer or DCIS had a significantly high calcium score.
None had a coronary calcium score >10 (Range 0–4), and none
had an aortic calcium score>20 (Range 0–19), among the patients
who had left-sided breast disease.
HISTORICAL CORRELATION
Historically, most cardiac disease has been observed in patients
receiving radiation to the left chest wall (3,4,12,13). Cause-specific
mortality by breast cancer laterality was analyzed in 54,617 patients
reported to the Swedish Cancer Registry during 1970–1985. After
a median follow up of 9 years, patients with left-sided tumors
were found to have a higher mortality due to MI, although, total
cardiovascular and inter-current mortality was not different in
both groups (3). In an epidemiologic cohort study, 300,000 US
women were followed prospectively for cause-specific mortality
and a higher risk of cardiac death was observed among patients
with left-sided breast cancer than those with right-sided breast
cancer, and this risk increased with time since treatment (14).
In a recent population-based case-control study involving more
than 2100 women who received adjuvant radiation for breast can-
cer between 1958 and 2001, there was a significant increase in
major coronary events for the left side vs. right-sided radiation
exposure (15). A linear relationship between radiation exposure
and rate of coronary events was found: 7.4% per gray (95% CI 2.9–
14.5; p< 0.001), and the effects began at 5 years post-radiation,
and continued for at least 20 years.
Therefore, recognition of the adverse effects of older radiother-
apy techniques has led to increased efforts to avoid inclusion of
the heart in the radiation field and the elimination of the gamma
radiation fields that were used to treat IMN. The change in deliv-
ery of radiation via linear accelerators alone has been shown to
substantially decrease radiation to the heart (16). Additionally, the
use of tangential fields was shown to avoid direct heart exposure
in the radiation field in more than 95% of patients (17). Many of
the above studies include women treated with older technique.
All patients included in our study were treated after 1990,
with modern techniques. Only 2 out of 20 received IMN radia-
tion (Patients #11 and #18), and neither patient had a calcium
score >10 of any vessel. The overall lack of adverse coronary
artery findings may suggest that concerns about radiation induced
CAD in breast cancer may not be applicable to current radiation
techniques.
It is unclear why only one patient had a significant calcium
score, and that contrary to expectations, she had no significant
personal or family history of risk factors, except for hyperlipi-
demia. It is possible there are yet unknown factors that lead
to accelerated atherosclerosis outside of traditional risk factors.
Indeed, there is growing evidence that the coronary calcium score
serves as an independent prognostic risk factor for coronary events
and mortality, irrespective of other traditional risk factors (18).
In this cohort study of 44,052 patients, individuals without any
traditional risk factors but with an elevated calcium score had a
significantly higher all-cause mortality rate than those who had
three or more risk factors, but had coronary calcium scores of 0.
Thus there may not be a direct correlation between having more
risk factors and having a higher coronary calcium score.
LIMITATIONS
Our study is limited by both size and duration of post-radiation
followup. No conclusion can be drawn from a small sample size,
however our findings may yield cautious optimism that modern
radiation techniques that minimize exposure to the heart and great
vessels may indeed reduce major cardiac events. The one patient
with a moderately elevated calcium score had radiation to the
right chest wall, and it is extremely unlikely that her calcium score
is related to her adjuvant radiation.
Despite a median of 8 years post-radiation followup time in
our study, we take note that the Swedish Cancer Registry study (3)
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was able to demonstrate cause-specific mortality with a median
9 year followup, in women who had radiation for left-sided vs.
right-sided breast cancers. Furthermore, the recent population-
based case-control data published by Darby et al. suggests that
major cardiac events occur as early as 5 years post-radiation expo-
sure. Thus we may reasonably anticipate elevations in coronary
and aortic calcium scores within the minimum 5 years followup
in our present study.
Other limitations are focused on the calcium scoring mech-
anism and the screening technology. Non-calcified plaques are
not detected by EBCT and this component of atherosclero-
sis may be overlooked. Also, newer, alternative calcium scor-
ing methods are being devised which may be superior to the
AGS and CVS. The Calcium Mass score has been touted as
more accurate than the AGS and CVS (19, 20). Also, lesion
and vessel specific coronary artery calcium scoring has been
shown to be superior to Agatston in the detection of obstructive
coronary artery disease (21). Despite the superior theoreti-
cal improvements in calcium detection with the newer cal-
culation methods, a study that directly compared the Agat-
ston, Calcium Volume, and Mass scores of 11,490 patients
found no significant difference in agreement between the three
methods (20).
CONCLUSION
In conclusion, this pilot study of 20 women did not find an increase
in coronary or aortic calcium burden by AGS or CVS in patients
treated with left-sided vs. right-sided chest wall radiation for adju-
vant therapy for early breast cancer or DCIS. This is contrary to
earlier data, and it is possible that newer radiation techniques that
minimize radiation exposure to the heart may account for our
findings. Larger, prospective trials with longer followup are needed
to clarify the role of coronary CT calcium scores in evaluating and
monitoring patients with prior breast irradiation.
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